Requirements for control of B-cell lymphoma by NK cells (Q39768943)

14 September 2017

title

Requirements for control of B-cell lymphoma by NK cells (English)

1 reference

14 September 2017

1 reference

6

Georg W Bornkamm

1 reference

14 September 2017

Christoph D Brenner

1

1 reference

14 September 2017

Susan King

2

1 reference

14 September 2017

Margarethe Przewoznik

3

1 reference

14 September 2017

Imke Wolters

4

1 reference

14 September 2017

Christian Adam

5

1 reference

14 September 2017

Dirk H Busch

7

1 reference

14 September 2017

Martin Röcken

8

1 reference

14 September 2017

Ralph Mocikat

9

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

European Journal of Immunology

14 September 2017

published in

1 reference

14 September 2017

volume

40

1 reference

14 September 2017

issue

2

1 reference

14 September 2017

page(s)

494-504

1 reference

A ligand for the murine NK activation receptor Ly-49D: activation of tolerized NK cells from beta 2-microglobulin-deficient mice

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

Cutting edge: novel priming of tumor-specific immunity by NKG2D-triggered NK cell-mediated tumor rejection and Th1-independent CD4+ T cell pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

Immature NK cells suppress dendritic cell functions during the development of leukemia in a mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

Intracellular retention of the NKG2D ligand MHC class I chain-related gene A in human melanomas confers immune privilege and prevents NK cell-mediated cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

NK cells and NKT cells in innate defense against viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

https://api.crossref.org/works/10.1002%2FEJI.200939937

1 reference

7 January 2021

Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

Receptors for HLA class-I molecules in human natural killer cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

Regulation of immune responses through inhibitory receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

Natural Killer Cells Activated by MHC Class ILow Targets Prime Dendritic Cells to Induce Protective CD8 T Cell Responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

Missing self recognition and self tolerance of natural killer (NK) cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

The role of the NKG2D receptor for tumor immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

The role of the NKG2D immunoreceptor in immune cell activation and natural killing

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

DC therapy induces long-term NK reactivity to tumors via host DC.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

Tumor-primed human natural killer cells lyse NK-resistant tumor targets: evidence of a two-stage process in resting NK cell activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

Burkitt lymphoma in the mouse.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

Intrinsic sensor of oncogenic transformation induces a signal for innate immunosurveillance.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

Natural killer cells in antiviral defense: function and regulation by innate cytokines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

Specific and nonspecific NK cell activation during virus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

Tumor growth impedes natural-killer-cell maturation in the bone marrow.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

STAT1 acts as a tumor promoter for leukemia development

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

Tumor cell recognition by the NK cell activating receptor NKG2D.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

Killers and beyond: NK-cell-mediated control of immune responses.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

Infection breaks T-cell tolerance.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

Synthesis, assembly, and secretion of gamma globulin by mouse myeloma cells. I. Adaptation of the Merwin plasma cell tumor-11 to culture, cloning, and characterization of gamma globulin subunits

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

„Natural”︁ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

Crystal structure of the murine NK cell-activating receptor NKG2D at 1.95 A

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

Coordinate regulation of complex T cell populations responding to bacterial infection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939937

7 January 2021

Identifiers

DOI

10.1002/EJI.200939937

1 reference

14 September 2017

1 reference